Dataset Information

Sentinel Node Identification in Melanoma: Current Clinical Impact, New Emerging SPECT Radiotracers and Technological Advancements. An Update of the Last Decade.

ABSTRACT: BACKGROUND:Melanoma is the most lethal skin cancer with a mortality rate of 262 cases per 100.000 cases. The sentinel lymph node (SLN) is the first lymph node draining the tumor. SLN biopsy is a widely accepted procedure in the clinical setting since it provides important prognostic information, which helps patient management, and avoids the side effects of complete lymph node dissection. The rationale of identifying and removing the SLN relies on the low probability of subsequent metastatic nodes in case of a negative histological exam performed in the SLN. DISCUSSION:Recently, new analytical approaches, based on the evaluation of scintigraphic images are also exploring the possibility to predict the metastatic involvement of the SLN. 99mTc-labeled colloids are still the most commonly used radiotracers but new promising radiotracers, such as 99mTc- Tilmanocept, are now on the market. In the last decades, single photon emission computed tomography- computerized tomography (SPECT/CT) has gained wider diffusion in clinical departments and there is large evidence about its superior diagnostic accuracy over planar lymphoscintigraphy (PL) in the detection of SLN in patients with melanoma. Scientists are also investigating new hybrid techniques combining functional and anatomical images for the depiction of SLN but further evidence about their value is needed. CONCLUSION:This review examined the predictive and prognostic factors of lymphoscintigraphy for metastatic involvement of SLN, the currently available and emerging radiotracers and the evidence of the additional value of SPECT/CT over PL for the identification of SLN in patients with melanoma. Finally, the review discussed the most recent technical advances in the field.

SUBMITTER: Quartuccio N

PROVIDER: S-EPMC7509753 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Sentinel Node Identification in Melanoma: Current Clinical Impact, New Emerging SPECT Radiotracers and Technological Advancements. An Update of the Last Decade.

Quartuccio Natale N Siracusa Massimiliano M Pappalardo Marco M Arnone Annachiara A Arnone Gaspare G

Current radiopharmaceuticals 20200101 1

<h4>Background</h4>Melanoma is the most lethal skin cancer with a mortality rate of 262 cases per 100.000 cases. The sentinel lymph node (SLN) is the first lymph node draining the tumor. SLN biopsy is a widely accepted procedure in the clinical setting since it provides important prognostic information, which helps patient management, and avoids the side effects of complete lymph node dissection. The rationale of identifying and removing the SLN relies on the low probability of subsequent metast ...[more]

PMID: 31749441

Similar Datasets

Project description:Electrochemotherapy, a combination of high voltage electric pulses and of an anticancer drug, has been demonstrated to be highly effective in treatment of cutaneous and subcutaneous tumors. Unique properties of electrochemotherapy (e.g., high specificity for targeting cancer cells, high degree of localization of treatment effect, capacity for preserving the innate immune response and the structure of the extracellular matrix) are facilitating its wide spread in the clinics. Due to high effectiveness of electrochemotherapy in treatment of cutaneous and subcutaneous tumors regardless of histological origin, there are now attempts to extend its use to treatment of internal tumors. To advance the applicability of electrochemotherapy to treatment of internal solid tumors, new technological developments are needed that will enable treatment of these tumors in daily clinical practice. New electrodes through which electric pulses are delivered to target tissue need to be designed with the aim to access target tissue anywhere in the body. To increase the probability of complete tumor eradication, the electrodes have to be accurately positioned, first to provide an adequate extent of electroporation of all tumor cells and second not to damage critical healthy tissue or organs in its vicinity. This can be achieved by image guided insertion of electrodes that will enable accurate positioning of the electrodes in combination with patient-specific numerical treatment planning or using a predefined geometry of electrodes. In order to be able to use electrochemotherapy safely for treatment of internal tumors located in relative proximity of the heart (e.g., in case of liver metastases), the treatment must be performed without interfering with the heart's electrical activity. We describe recent technological advances, which allow treatment of liver and bone metastases, soft tissue sarcomas, brain tumors, and colorectal and esophageal tumors. The first clinical experiences in these novel application areas of electrochemotherapy are also described.

Project description:Plant production systems such as plant factories and greenhouses can help promote resilience in food production. These systems could be used for plant protection and aid in controlling the micro- and macro- environments needed for optimal plant growth irrespective of natural disasters and changing climate conditions. However, to ensure optimal environmental controls and efficient production, several technologies such as sensors and robots have been developed and are at different stages of implementation. New and improved systems are continuously being investigated and developed with technological advances such as robotics, sensing, and artificial intelligence to mitigate hazards to humans working in these systems from poor ventilation and harsh weather while improving productivity. These technological advances necessitate frequent retrofits considering local contexts such as present and projected labor costs. The type of agricultural products also affects measures to be implemented to maximize returns on investment. Consequently, we formulated the retrofitting problem for plant production systems considering two objectives; minimizing the total cost for retrofitting and maximizing the yearly net profit. Additionally, we considered the following: (a) cost of new technologies; (b) present and projected cost for human labor and robotics; (c) size and service life of the plant production system; (d) productivity before and after retrofit, (e) interest on loans for retrofitting, (f) energy consumption before and after retrofit and, (g) replacement and maintenance cost of systems. We solved this problem using a multi-objective evolutionary algorithm that results in a set of compromised solutions and performed several simulations to demonstrate the applicability and robustness of the method. Results showed up to a 250% increase in annual net profits in an investigated case, indicating that the availability of all the possible retrofitting combinations would improve decision making. A user-friendly system was developed to provide all the feasible retrofitting combinations and total costs with the yearly return on investment in agricultural production systems in a single run.

Dataset Information

Sentinel Node Identification in Melanoma: Current Clinical Impact, New Emerging SPECT Radiotracers and Technological Advancements. An Update of the Last Decade.

Publications

Sentinel Node Identification in Melanoma: Current Clinical Impact, New Emerging SPECT Radiotracers and Technological Advancements. An Update of the Last Decade.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets